VI
CERE

Vestcor Inc’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Vestcor Inc’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-50,000
Closed -$2.04M – 1230
2024
Q2 		$2.04M Sell
50,000
-67,400
-57% -$2.81M 0.07% 265
2024
Q1 		$4.96M Buy
117,400
+67,400
+135% +$2.83M 0.17% 146
2023
Q4 		$2.12M Buy
+50,000
New +$1.44M 0.07% 273

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Vestcor Inc's CERE Position: Q3 2024 in Review

Vestcor Inc sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 50,000 shares — an estimated $2.04M sold.

Vestcor Inc first reported a position in CERE in Q4 2023 and held it in 3 quarters. The position peaked at $4.96M in Q1 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Vestcor Inc reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Vestcor Inc sold 50,000 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $2.04M.
  • Vestcor Inc first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
  • Vestcor Inc's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $4.96M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Vestcor Inc's 13F filing for Q3 2024, filed 15 Nov 2024.